May 26, 2003
Contact:
Nancy Lawrence
Communications Consultant, LHSC
519-685-8500, ext. 77642
Integrated Cancer Care Vice-President assumes new role in London
(LONDON, Ontario) London has another medical leader in town. Tony Dagnone, President and CEO, London Health Sciences Centre, and Dr. Alan Hudson, President and CEO, Cancer Care Ontario, are pleased to announce the appointment of Michael Sherar, Ph.D, to the newly created position of Vice President, Integrated Cancer Program, London. Dr. Sherar assumed his new role in London on May 15.
Dr. Sherar, in partnership with the Senior Medical Director and other key leaders and organizations in Southwestern Ontario, will be responsible for the strategic and operational leadership for an integrated and comprehensive oncology program. He brings more than 10 years of leadership experience in oncology to his new role.
"I am very excited to be working with the outstanding teams at London Health Sciences Centre and London Regional Cancer Centre to build an Integrated Cancer Program," says Dr. Sherar.
"I look forward to contributing to the provision of the best cancer care for patients in the London region through our clinical programs, research and education."
London's stellar reputation as a medical centre of excellence assisted in recruitment efforts for this position.
"Dr. Sherar has worked with a number of public and private sector partners to advance research and development in the field of oncology. One of the most successful and innovative partnerships has been the creation of the Ontario Consortium for Image Guided Therapy and Surgery (OCITS)," says Dagnone.
"In addition, Dr. Sherar and his research team were the first in the world to develop microwave thermal therapy for recurrent prostate cancer. We are very pleased to welcome him to London," adds Dagnone.
London Health Sciences Centre (LHSC)
Dr. MICHAEL SHERAR BIOGRAPHY:
Dr. Sherar has a Ph.D in Medical Biophysics from the University of Toronto, and an undergraduate degree in Physics from the University of Oxford, England. He is a leading scientist, associate professor and has recently held a key clinical leadership role as the Head of Department of Radiation Physics at Princess Margaret Hospital (PMH) in Toronto. In this role, Dr. Sherar was able to build program excellence and attract internationally recognized physicists for PMH.
He held a leadership role at the University Health Network (UHN incorporating PMH, Toronto General Hospital and Toronto Western Hospital) on program development in the field of Medical Technology Innovation (MTI). He was a member of the Governing Council of the School of Graduate Studies (SGS), University of Toronto.
Dr. Sherar recently received Canada's "Top 40 under 40" award for his research and clinical leadership and innovation in oncology.
